Long-Acting HIV Therapy Gains Ground in Both New and Experienced Patients
|
Nearly 90% of treatment-naïve people with HIV chose
to switch to long-acting injectable therapy after achieving viral
suppression, according to ... |
HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study
The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from ... View article...